USPTO to Reexamine Roche Nucleic Acid Amplification and Detection Patent

The patent reexamination is intended to challenge a larger "PCR patents duopoly" enjoyed by Roche and Life Technologies, according to an associate at the IP firm that initiated the patent reexamination last month.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.